Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Antimicrobial Agents and Chemotherapy
H C Neu, P Labthavikul

Abstract

The in vitro activity of N-formimidoyl thienamycin was determined against 800 gram-positive and gram-negative aerobic and anaerobic bacteria and compared with the activity of cefoxitin, cefazolin, cefamandole, cefotaxime, moxalactam, ampicillin, cefoperazone, and gentamicin. N-Formimidoyl thienamycin inhibited the majority of organisms at concentrations below 1 microgram/ml. It inhibited methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, and Streptococcus faecalis. It inhibited beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae. Unlike other new beta-lactams, it inhibited Listeria. Escherichia coli, Klebsiella pneumoniae, enterobacters, Serratia, indole-positive Proteus, Acinetobacter, Pseudomonas aeruginosa, and Bacteroides resistant to other agents were inhibited. There was minimal effect of inoculum size and aerobic versus anaerobic conditions, and serum had no effect on activity. Most minimal bactericidal concentrations were two- or fourfold greater than the minimal inhibitory concentration. N-Formimidoyl thienamycin showed partial synergy with aminoglycosides against S. aureus, S. faecalis, and many Pseudomonas and Enterobacteriaceae. It was not hydrolyzed by plasmid-mediated an...Continue Reading

References

Aug 1, 1979·Antimicrobial Agents and Chemotherapy·H C NeuP Aswapokee
Apr 1, 1979·Antimicrobial Agents and Chemotherapy·S S WeaverB M LeBlanc
Sep 1, 1978·Antimicrobial Agents and Chemotherapy·F P TallyS L Gorbach
Mar 1, 1981·Antimicrobial Agents and Chemotherapy·L Verbist, J Verhaegen
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·H KroppJ Birnbaum

❮ Previous
Next ❯

Citations

Jan 1, 1987·Cancer Metastasis Reviews·K H Mayer, S M Opal
Oct 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y SumitaS Mitsuhashi
Feb 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I OdenholtO Cars
Mar 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J P Quinn
Apr 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A GiacomettiG Scalise
Oct 1, 1984·European Journal of Clinical Microbiology·I Braveny
Oct 1, 1984·European Journal of Clinical Microbiology·G RuckdeschelA Ahl
Oct 1, 1984·European Journal of Clinical Microbiology·R F JacobsR B Kluza
Oct 1, 1984·European Journal of Clinical Microbiology·C PonteM Santamaria
Apr 1, 1987·European Journal of Clinical Microbiology·M EdelmannW Kozuschek
Jun 7, 1985·The American Journal of Medicine·R N Jones
Mar 1, 1985·Diagnostic Microbiology and Infectious Disease·A L BarryR Kundargi
Jul 1, 1983·The Journal of Pediatrics·M I Marks
Aug 1, 1997·Journal of the American Academy of Dermatology·M E EpsteinN S Sadick
Jan 13, 2011·The Journal of Antibiotics·Shunkichi TanakaHiroaki Shirahase
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·T D Gootz, C C Sanders
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·M E GombertM C Cummings
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·L J EronD M Poretz
Feb 1, 1984·Antimicrobial Agents and Chemotherapy·H GnarpeA Lundbäck
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·Y SainoS Mitsuhashi
Aug 1, 1984·Antimicrobial Agents and Chemotherapy·H SaitoB W Jin
Aug 1, 1984·Antimicrobial Agents and Chemotherapy·M A Bertram, L S Young
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·D J WinstonR W Busuttil
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·B J FreijN Threlkeld
May 1, 1985·Antimicrobial Agents and Chemotherapy·B A ZajacR R MacGregor
Jul 1, 1985·Antimicrobial Agents and Chemotherapy·F TauskC W Stratton
Nov 1, 1985·Antimicrobial Agents and Chemotherapy·R A Proctor, J A Textor
Dec 1, 1987·Antimicrobial Agents and Chemotherapy·M J LynchH L Mobley
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·A E Studemeister, J P Quinn
Feb 1, 1989·Antimicrobial Agents and Chemotherapy·L KagerC E Nord
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·K UbukataS Mitsuhashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.